02-28-2018 12:10 PM CET - Health & Medicine

Nicotine Addiction Key Players - Addex Therapeutics Ltd, CV Sciences Inc, and Hager Biosciences LLC Market Analysis & Forecast 2018 to 2022

Press release from: WiseGuy Research consultants Pvt Ltd.
Nicotine Addiction
Nicotine Addiction
Nicotine Addiction


Nicotine addiction also called tobacco dependence is an addiction to tobacco products caused by the drug nicotine. Predisposing factors include age, depression, schizophrenia, post-traumatic stress disorder and alcoholism. Person experiences withdrawal symptoms at cessation of using, such as shaky hands, sweating, irritability, or rapid heart rate. Treatment includes nicotine replacement therapy (NRT).

Click here for sample report @ www.wiseguyreports.com/sample-request/2989083-nicotine-ad...

Top Companies mentioned

Addex Therapeutics Ltd

C4X Discovery Holdings PLC

Chronos Therapeutics Ltd

CV Sciences Inc

Hager Biosciences LLC

Heptares Therapeutics Ltd

Omeros Corp

Nicotine Addiction Industry Major Outlook

Pharmaceutical and Healthcare latest pipeline guide Nicotine Addiction - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Nicotine Addiction, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Nicotine Addiction (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Nicotine Addiction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 1, 1, 12 and 2 respectively. Similarly, the Universities portfolio in Phase II, Preclinical and Discovery stages comprises 1, 4 and 1 molecules, respectively.

Nicotine Addiction - Competitive Analysis

Key players are making innovative developments in Nicotine Addiction industry.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector


The pipeline guide provides a snapshot of the global therapeutic landscape of Nicotine Addiction.

The pipeline guide reviews pipeline therapeutics for Nicotine Addiction by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Nicotine Addiction therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Nicotine Addiction therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects. 

The pipeline guide reviews latest news related to pipeline therapeutics for Nicotine Addiction.


For Detailed Reading Please visit @ www.wiseguyreports.com/reports/2989083-nicotine-addiction...

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.
News-ID: 960912 • Views: 180
More releases More releases

You can edit or delete your press release here: